• Home
  • NEW DAY MEDICINE
  • 7(45)2022
  • 31 — 7 (45) 2022 — Ruziyev A.E., Ruziev A.A., Urakova K.Kh., THE IMPORTANCE OF LYMPHOTROPIC CIRCULATION IN THE MESENA OF THE INTESTINAL FOR LYMPHOTROPIC THERAPY IN ULTRA COLITIS

31 — 7 (45) 2022 — Ruziyev A.E., Ruziev A.A., Urakova K.Kh., THE IMPORTANCE OF LYMPHOTROPIC CIRCULATION IN THE MESENA OF THE INTESTINAL FOR LYMPHOTROPIC THERAPY IN ULTRA COLITIS

THE IMPORTANCE OF LYMPHOTROPIC CIRCULATION IN THE MESENA OF THE INTESTINAL FOR LYMPHOTROPIC THERAPY IN ULTRA COLITIS

Ruziyev A.E.,Bukhara State Medical Institute, Uzbekistan

Ruziev A.A.,Bukhara State Medical Institute, Uzbekistan

Urakova K.Kh.,Bukhara State Medical Institute, Uzbekistan

Resume

This article examines the definitions of lymph circulation in the intestinal mesentery system in normal conditions and in the UC model, as well as the management and treatment of patients with ulcerative colitis using lymphotropic therapy in the postoperative period.
The aim of this work is to study and evaluate the non-refuting value of lymphotropic therapy in patients in the complex treatment of UC in the postoperative period.
Material and methods – in serial experiments on animals – dogs, in an experiment, we have created a model of ulcerative colitis, and at the same time, before and after the creation of the model, we studied the lymph circulation in the intestinal mesentery. Based on the results of experimental studies, in a clinical setting, lymphotropic therapy was used in the complex treatment of ulcerative colitis in the postoperative period in 54 patients.
Results: When using lymphotropic therapy in the complex treatment of ulcerative colitis, the number of intestinal complications in the postoperative period significantly decreases and the patient’s stay in the hospital is reduced

First page

150

Last page

154

For citation: Ruziyev A.E., Ruziev A.A., Urakova K.Kh., THE IMPORTANCE OF LYMPHOTROPIC CIRCULATION IN THE MESENA OF THE INTESTINAL FOR LYMPHOTROPIC THERAPY IN ULTRA COLITIS //New Day in Medicine 7(45)2022 150-154 https://l.clck.bar/ebc12

LIST OF REFERENCES:

  1. Adler G. Crohn’s disease and ulcerative colitis / G. Adler – M. GEOTAR. Medicine 2001, 527p.).
  2. Vorobiev, G.I. Nonspecific inflammatory bowel diseases / Vorobiev G.I., Khalif I.L. – M: Miklos, 2008, P.400.
  3. Grigorieva G.A., Meshalkina N.Yu. Crohn’s disease. – M .: Medicine, 2007., P.84.
  4. Maseevich index: A new approach to assessing the clinical and endoscopic activity of ulcerative colitis // Asanin Yu.Yu. et al. Gastroenterology. St. Petersburg. 2004, №1. S. P.14-16.
  5. Poluektova E.A., Lyashenko O.S., Korolev A.V. Mechanisms that ensure the interaction of bacterial cells with the host organism and their disruption in patients with inflammatory bowel diseases. // Russian journal of gastroenterology, hepatology, coloproctology. 2014., № 5. S. P. 42-53.
  6. Sekacheva M.I. Modern aspects of the treatment of ulcerative colitis: the results of evidence-based medicine / MI Sekacheva // Consilium Medicum [Electronic resource]. – 2003, T.5, №10. Access mode http: www. consiliumedicum. com/media/consilium/ 03_10c/ 18shtmi).
  7. Suvorova G.N., Myakisheva Yu.V., Katorkin S.E., Andreev P.S., Davydova O.E., Lyamin A.V., Kruglov E.E., Sukhachev P.A. Histological picture and microbial landscape in ulcerative colitis // Bulletin of new medical technologies. 2018., №4. S. P. 170-175.
  8. Khalif I.L. Surgical treatment and biological therapy for ulcerative colitis // Khalif I.L. Russian medical journal. 2013., №31., 1632).
  9. Khalif I.L. Inflammatory bowel diseases (ulcerative colitis and Crohn’s disease): clinical presentation, diagnosis and treatment. – M .: Miklos, 2008.
  10. Khalif I.L. Therapeutic tactics for ulcerative colitis // Khalif I.L. Russian Journal of Gastroenterology, Hepatology and Colopractology. 2006., №3., S. P. 58-61.
  11. Egamov Yu.S., Ruziev A.E., Khaidarov S.A. Endomesenteric lymphotropic therapy as a method of preventing complications in the complex treatment of ulcerative colitis in the postoperative period//New Day in Medicine 3(27)2019 299-302 https://cutt.ly/CbxB4Kc
  12. Dorofeev A.É., Shvets O.V. Epidemiology and risk factors of inflammatory bowel diseases. LikSprava. 2014; (11): 22-9.
  13. Langan R.C., Gotsch P.B., Krafczyk M.A. et al. Ulcerative colitis: diagnosis and treatment. Am Fam Physician. 2007; 76 (9): 1323-30.
  14. Marinov V. Investigation of two models of trinitrobenzenesulfonicacidnduced colitis in rats //Trakia Journal of Sciences. 2015. Vol. 13, Suppl. 2.P. 49–54.
  15. Novel features of tea rat model of inflammatory bowel disease based on 2,4,6- trinitrobenzenesulfonic acid-induced acute colitis / Szalai Z. et al. // ActaBiologicaSzegediensis/ – 2014. – Vol. 58(2). P.127-132.

file

download